Second-line afatinib significantly improves PFS in metastatic head and neck canc...
Dr Jean-Pascal Machiels - Cliniques Universitaires Saint-Luc, Brussels, Belgium
Second-line afatinib significantly improves PFS in metastatic head and neck cancer ( Dr Jean-Pascal Machiels - Cliniques Universitaires Saint-Luc, Brussels, Belgium )
27 Sep 2014
Networking and collaborating across borders in sub-Saharan Africa
Dr Shubhra Ghosh - Project Director of Global Programs, MD Anderson Cancer Cent...
Networking and collaborating across borders in sub-Saharan Africa ( Dr Shubhra Ghosh -  Project Director of Global Programs, MD Anderson Cancer Centre, Houston, USA )
26 Jun 2014
Phase III SELECT trial shows lenvatinib to be effective in resistant thyroid can...
Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France
Phase III SELECT trial shows lenvatinib to be effective in resistant thyroid cancer ( Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France )
2 Jun 2014
ASCO 2014 roundup
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ASCO 2014 roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
2 Jun 2014
Lapatinib not found to be beneficial in head and neck cancer with high risk of r...
Prof Kevin Harrington - Institute of Cancer Research, London, UK
Lapatinib not found to be beneficial in head and neck cancer with high risk of recurrence ( Prof Kevin Harrington - Institute of Cancer Research, London, UK )
2 Jun 2014
Lenvatinib yields high response rates and delays progression in radioiodine-resi...
Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France
Lenvatinib yields high response rates and delays progression in radioiodine-resistant, advanced differentiated thyroid cancer ( Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France )
31 May 2014
Phase II trial shows dacomitinib benefits a subgroup of patients with head and n...
Dr Byoung Chul Cho - Yonsei University College of Medicine, Seoul, Republic of K...
Phase II trial shows dacomitinib benefits a subgroup of patients with head and neck cancer ( Dr Byoung Chul Cho - Yonsei University College of Medicine, Seoul, Republic of Korea )
1 May 2014
Role of AORTIC in dealing with rising cancer rates in Africa
North American Vice president of AORTIC
Role of AORTIC in dealing with rising cancer rates in Africa ( North American Vice president of AORTIC )
1 May 2014
The relationship between obesity and cancer, and other dietary factors
Dr Walter C. Willett - Harvard School of Public Health, Boston, USA
The relationship between obesity and cancer, and other dietary factors ( Dr Walter C. Willett - Harvard School of Public Health, Boston, USA )
25 Apr 2014
Engineering of polymeric nanoparticles for medical applications
Dr Omid Farokhzad - Harvard Medical School, Boston, USA
Engineering of polymeric nanoparticles for medical applications ( Dr Omid Farokhzad - Harvard Medical School, Boston, USA )
14 Nov 2013
ecancermedicalscience Editor's Choice: Robotic surgery in oncology
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice: Robotic surgery in oncology ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
22 Oct 2013
Stem cell therapy for prevention of radiation-induced salivary gland toxicity
Dr Rob Coppes - University of Groningen, Netherlands
Stem cell therapy for prevention of radiation-induced salivary gland toxicity ( Dr Rob Coppes - University of Groningen, Netherlands )
7 Oct 2013